CD Biosynsis offers integrated Saccharomyces cerevisiae Metabolic Pathway Optimization Services, designed to maximize the yield and productivity of target compounds in this versatile eukaryotic host. Saccharomyces cerevisiae (baker's yeast) is the premier eukaryotic chassis, ideal for synthesizing complex molecules requiring post-translational modifications (PTMs) and intracellular compartmentalization. Our optimization services utilize a systematic approach that combines Constraint-Based Metabolic Modeling (CBM), high-precision gene editing (CRISPR-Cas9, Base Editing), and tunable gene regulation (CRISPRi). This integrated strategy allows for the rapid identification and removal of metabolic bottlenecks, precise tuning of enzyme expression levels, and efficient redirection of carbon flux, ensuring the industrial viability of complex engineered pathways within the Saccharomyces cerevisiae system.
Get a QuoteOptimizing a metabolic pathway in Saccharomyces cerevisiae requires precise management of the cell's unique eukaryotic characteristics, such as the compartmentalization of reactions and the regulatory effects of the nucleus. Our platform employs a systematic cycle where computational modeling (Design) guides the construction of engineered strains (Build). Phenotypic testing (Test) and data analysis (Learn) inform the next round of rational modifications. This systematic, data-driven methodology eliminates reliance on trial-and-error, allowing us to rapidly achieve high product titers, especially for pathways involving complex eukaryotic protein folding and localization.
Constraint-Based Modeling (CBM)
Utilization of the Saccharomyces cerevisiae genome-scale model to predict maximum theoretical yields and identify optimal gene knockouts for flux redirection to the target product, accounting for compartmentalization.
Metabolomics & Fluxomics
Experimental measurement of intracellular metabolite levels and metabolic fluxes (via 13C tracing) to pinpoint rate-limiting enzymatic steps (bottlenecks) in the pathway.
Compartmental Analysis
Modeling of mitochondrial, cytoplasmic, and peroxisomal fluxes to ensure engineered pathways are correctly localized for optimal cofactor regeneration and activity in Saccharomyces cerevisiae.
CRISPR-Cas9 Editing
High-efficiency permanent gene knockouts or large chromosomal knock-ins, leveraging the high efficiency of the Saccharomyces cerevisiae Homology-Directed Repair (HDR) system.
Base Editing (BE)
Precision single-nucleotide substitutions (C>T, A>G) for fine-tuning promoter/RBS strength or optimizing enzyme kcat without introducing DSBs.
CRISPR Interference (CRISPRi)
Tunable and reversible gene knockdown (partial repression) used for balancing flux through essential or highly sensitive native pathways.
PTM and Folding Optimization
Engineering the Saccharomyces cerevisiae ER/Golgi apparatus and chaperone network to improve protein folding, disulfide bond formation, and PTMs for heterologous enzymes.
Module Co-Localization
Targeting pathway enzymes to specific organelles (e.g., peroxisomes, mitochondria) via signal sequences to enhance intermediate channeling and prevent toxicity.
Promoter Library Screening
Utilization of standardized Saccharomyces cerevisiae promoter libraries with varying strengths to quickly screen and select the optimal expression level for each pathway enzyme.
A systematic process for rational pathway design and optimization.
1. Initial Modeling & Target Identification
2. Precision Editing & Module Construction
3. Phenotype Testing & Assay
4. Data Integration & Refinement
Establish a metabolic model and analyze flux. Identify key targets for deletion, insertion, or tuning (KO/KI/Tuning).
Design expression modules including eukaryotic promoters and localization tags.
Select appropriate chromosomal integration site(s) using rational design principles.
Construct gene circuits, operons, and editing tools (CRISPR-Cas9, Base Editor, CRISPRi).
Introduce modifications into the Saccharomyces cerevisiae genome, leveraging the high efficiency of HDR for multi-copy/multi-site integration.
Verify genotype of the initial engineered strains.
Integrate experimental data to validate and refine the computational model.
Identify prediction errors and calculate the next set of rational genetic modifications (e.g., adjustment of localization tags or promoter strength).
Deliver the optimized Saccharomyces cerevisiae production strain.
Eukaryotic Fidelity
The Saccharomyces cerevisiae chassis provides native folding, PTM, and compartmentalization machinery essential for producing complex, functional proteins and intermediates, unlike prokaryotic hosts.
High Precision HDR
Leveraging yeast's robust HDR ensures stable and clean integration of large biosynthetic pathways (multi-gene knock-in) directly into the chromosome, eliminating plasmid instability.
Targeted Localization
Expertise in adding signal peptides and localization tags to enzymes to direct them to the optimal organelle (e.g., mitochondria, peroxisomes) for enhanced pathway efficiency.
Integrated Flux Control
Uses a combination of CRISPR-Cas9 (KO/KI) and CRISPRi/Base Editing (Tuning) guided by modeling to achieve superior, balanced metabolic flux control.
1. Why is Saccharomyces cerevisiae often preferred for complex pathways?
As a eukaryote, Saccharomyces cerevisiae possesses organelles (like the ER, Golgi, and mitochondria) and native PTM machinery that are essential for the correct folding and modification of complex pathway enzymes (e.g., P450s, large synthases).
2. How does metabolic modeling account for yeast compartmentalization?
The Saccharomyces cerevisiae genome-scale model is compartmentalized, meaning the model tracks metabolic reactions and fluxes separately within the cytoplasm, mitochondria, and other organelles, which is crucial for rational design.
3. Can you optimize a pathway that uses enzymes requiring disulfide bonds?
Yes. The Saccharomyces cerevisiae endoplasmic reticulum (ER) provides the oxidizing environment and chaperones necessary for correct disulfide bond formation, making it a reliable host for such enzymes.
4. How is the localization of engineered enzymes controlled?
We control enzyme localization by adding specific signal peptides or localization tags (e.g., mitochondrial or peroxisomal targeting sequences) to the enzyme's coding sequence before chromosomal integration.
5. Why use Base Editing for tuning instead of promoter swapping?
Base Editing provides single-base resolution for tuning promoter/RBS strength without relying on a library of pre-characterized promoters, allowing for finer, more precise control over gene expression than standard swapping methods.
6. How does Homology-Directed Repair (HDR) benefit pathway optimization?
Yeast's highly efficient HDR allows for stable, clean, and simultaneous integration of large pathways (multi-gene knock-in) directly into the chromosome, ensuring genetic stability during scale-up.
7. What output data is provided upon completion of the service?
We deliver the optimized Saccharomyces cerevisiae strain, all final sequences, and a detailed report including product titer and yield data, metabolic flux analysis (if requested), and the final predictive metabolic model used for the optimization.
8. Can you engineer the yeast to utilize non-standard carbon sources?
Yes. A common optimization strategy involves integrating heterologous genes (e.g., transporters and isomerases) to allow Saccharomyces cerevisiae to efficiently consume low-cost feedstocks like xylose or arabinose.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.